Filing Details

Accession Number:
0001140361-10-021251
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-14 13:00:00
Reporting Period:
2010-05-12
Filing Date:
2010-05-14
Accepted Time:
2010-05-14 13:10:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1375247 Obagi Medical Products Inc. OMPI Pharmaceutical Preparations (2834) 954658730
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1382901 S. David Goldstein C/O Obagi Medical Products, Inc.
3760 Kilroy Airport Way, Suite 500
Long Beach CA 90806
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-12 41,667 $8.40 64,167 No 4 M Direct
Common Stock Acquisiton 2010-05-12 150 $10.80 64,317 No 4 M Direct
Common Stock Disposition 2010-05-12 41,817 $13.63 22,500 No 4 S Direct
Common Stock Acquisiton 2010-05-13 8,184 $10.80 30,684 No 4 M Direct
Common Stock Acquisiton 2010-05-13 417 $10.00 31,101 No 4 M Direct
Common Stock Disposition 2010-05-13 8,601 $13.55 22,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2010-05-12 41,667 $0.00 41,667 $8.40
Common Stock Employee Stock Option (right to buy) Disposition 2010-05-12 150 $0.00 150 $10.80
Common Stock Employee Stock Option (right to buy) Disposition 2010-05-13 8,184 $0.00 8,184 $10.80
Common Stock Employee Stock Option (right to buy) Disposition 2010-05-13 417 $0.00 417 $10.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
208,751 2015-03-01 No 4 M Direct
208,601 2015-10-31 No 4 M Direct
200,417 2015-10-31 No 4 M Direct
200,000 2011-03-31 No 4 M Direct
Footnotes
  1. Such transaction was executed in multiple trades at prices ranging from $13.42 to $13.91. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
  2. Such transaction was executed in multiple trades at prices ranging from $13.50 to $13.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
  3. Fully vested and immediately exercisable.